{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:23:25Z","timestamp":1794543805531,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774247"],"award-info":[{"award-number":["81774247"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81804045"],"award-info":[{"award-number":["81804045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MH134"],"award-info":[{"award-number":["ZR2020MH134"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.biopha.2021.112133","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T22:49:51Z","timestamp":1630363791000},"page":"112133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"special_numbering":"C","title":["MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis"],"prefix":"10.1016","volume":"143","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cundong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Tao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112133_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drudis.2016.11.005","article-title":"Doxorubicin: nanotechnological overviews from bench to bedside","volume":"22","author":"Cagel","year":"2017","journal-title":"Drug Disco Today"},{"key":"10.1016\/j.biopha.2021.112133_bib2","doi-asserted-by":"crossref","first-page":"H1236","DOI":"10.1152\/ajpheart.00121.2018","article-title":"PTEN inhibitor VO-OHpic attenuates inflammatory M1 macrophages and cardiac remodeling in doxorubicin-induced cardiomyopathy","volume":"315","author":"Johnson","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2021.112133_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","article-title":"Molecular mechanism of doxorubicin-induced cardiomyopathy - an update","volume":"818","author":"Renu","year":"2018","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2021.112133_bib4","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2017.09.1096","article-title":"Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1","volume":"70","author":"Chang","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2021.112133_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.critrevonc.2017.12.005","article-title":"Protective effects of curcumin against doxorubicin-induced toxicity and resistance: a review","volume":"122","author":"Mohajeri","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biopha.2021.112133_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/med.21463","article-title":"Breakthroughs in modern cancer therapy and elusive cardiotoxicity: critical research-practice gaps, challenges, and insights","volume":"38","author":"Zheng","year":"2018","journal-title":"Med Res Rev."},{"key":"10.1016\/j.biopha.2021.112133_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.112133_bib8","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological inhibitors of the NLRP3 inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2021.112133_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.112133_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2021.112133_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.redox.2018.02.013","article-title":"Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis","volume":"16","author":"Han","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2021.112133_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2021.112133_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12012-020-09576-4","article-title":"Involvement of ROS\/NLRP3 inflammasome signaling pathway in doxorubicin-induced cardiotoxicity","volume":"20","author":"Wei","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.biopha.2021.112133_bib14","doi-asserted-by":"crossref","first-page":"H460","DOI":"10.1152\/ajpheart.00056.2019","article-title":"Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis","volume":"317","author":"Tavakoli Dargani","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2021.112133_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2021.112133_bib16","first-page":"828","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction","volume":"38","author":"van Hout","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2021.112133_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.intimp.2019.02.016","article-title":"The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice","volume":"70","author":"Qu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.112133_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.gastro.2019.09.040","article-title":"NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis","volume":"158","author":"Sendler","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2021.112133_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10787-020-00730-6","article-title":"Novel complementary coloprotective effects of metformin and MCC950 by modulating HSP90\/NLRP3 interaction and inducing autophagy in rats","volume":"29","author":"Saber","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2021.112133_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014044","article-title":"Targeting the NLRP3 inflammasome with inhibitor MCC950 prevents aortic aneurysms and dissections in mice","volume":"9","author":"Ren","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2021.112133_bib21","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1161\/ATVBAHA.117.309575","article-title":"NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein e-deficient mice-brief report","volume":"37","author":"van der Heijden","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2021.112133_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106394","article-title":"Ameliorative effect of selective NLRP3 inflammasome inhibitor MCC950 in an ovalbumin-induced allergic rhinitis murine model","volume":"83","author":"Zhang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.112133_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yjmcc.2019.08.009","article-title":"Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3","volume":"136","author":"Meng","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2021.112133_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12277","article-title":"Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation","volume":"35","author":"Bai","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.biopha.2021.112133_bib25","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1161\/CIRCULATIONAHA.108.823799","article-title":"Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction","volume":"119","author":"Doser","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2021.112133_bib26","doi-asserted-by":"crossref","first-page":"H1466","DOI":"10.1152\/ajpheart.00795.2008","article-title":"Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro","volume":"296","author":"Mukhopadhyay","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2021.112133_bib27","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1038\/s41598-017-12060-9","article-title":"Neferine ameliorates cardiomyoblast apoptosis induced by doxorubicin: possible role in modulating NADPH oxidase\/ROS-mediated NF\u03baB redox signaling cascade","volume":"7","author":"Priya","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.112133_bib28","doi-asserted-by":"crossref","first-page":"13431","DOI":"10.1111\/jcmm.15966","article-title":"Doxorubicin hydrochloride enhanced antitumour effect of CEA-regulated oncolytic virotherapy in live cancer cells and a mouse model","volume":"24","author":"Xiao","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2021.112133_bib29","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41419-018-0797-1","article-title":"Downregulation of miR-130a, antagonized doxorubicin-induced cardiotoxicity via increasing the PPAR\u03b3 expression in mESCs-derived cardiac cells","volume":"9","author":"Pakravan","year":"2018","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2021.112133_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/mol.119.115725","article-title":"Insights into doxorubicin-induced cardiotoxicity: molecular mechanisms, preventive strategies, and early monitoring","volume":"96","author":"Wenningmann","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2021.112133_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yjmcc.2018.11.019","article-title":"Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity","volume":"126","author":"Llach","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2021.112133_bib32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2147\/IJN.S235832","article-title":"Liquiritigenin-loaded submicron emulsion protects against doxorubicin-induced cardiotoxicity via antioxidant, anti-inflammatory, and anti-apoptotic activity","volume":"15","author":"Shi","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2021.112133_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2021.112133_bib34","doi-asserted-by":"crossref","first-page":"20969","DOI":"10.1002\/jcp.28701","article-title":"Melatonin attenuates TNF-alpha-mediated hepatocytes damage via inhibiting mitochondrial stress and activating the Akt-Sirt3 signaling pathway","volume":"234","author":"Song","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2021.112133_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/FJC.0000000000000350","article-title":"Docosahexaenoic acid attenuates doxorubicin-induced cytotoxicity and inflammation by suppressing NF-kappaB\/iNOS\/NO signaling pathway activation in H9C2 cardiac cells","volume":"67","author":"Wang","year":"2016","journal-title":"J. Cardiovasc Pharm."},{"key":"10.1016\/j.biopha.2021.112133_bib36","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2021.112133_bib37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12015-020-09953-0","article-title":"Novel evidence that purinergic signaling - Nlrp3 inflammasome axis regulates circadian rhythm of hematopoietic stem\/progenitor cells circulation in peripheral blood","volume":"16","author":"Adamiak","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.biopha.2021.112133_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2020.116403","article-title":"Cadmium and molybdenum co-induce pyroptosis via ROS\/PTEN\/PI3K\/AKT axis in duck renal tubular epithelial cells","volume":"272","author":"Zhang","year":"2021","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.biopha.2021.112133_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/science.aas8995","article-title":"HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation","volume":"369","author":"Magupalli","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.112133_bib40","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/cdd.2008.91","article-title":"Cell death in the host response to infection","volume":"15","author":"Labbe","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2021.112133_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2958.2000.02103.x","article-title":"Salmonella induces macrophage death by caspase-1-dependent necrosis","volume":"38","author":"Brennan","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.biopha.2021.112133_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00361-18","article-title":"Caspase-1 and caspase-11 mediate pyroptosis, inflammation, and control of brucella joint infection","volume":"86","author":"Lacey","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2021.112133_bib43","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1073\/pnas.1607769113","article-title":"GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes","volume":"113","author":"Aglietti","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biopha.2021.112133_bib44","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2021.112133_bib45","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2020.02.002","article-title":"Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis","volume":"180","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2021.112133_bib46","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221009173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221009173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:41:15Z","timestamp":1771918875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221009173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":46,"alternative-id":["S0753332221009173"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112133","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112133"}}